Conditions: Influenza
Keywords: Drug Therapy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 55
Healthy volunteers: yes

Brief summary:
This clinical trial is a phase 1/2 study of a single intramuscular injection of TAK-850 in healthy Japanese adult participants

Detailed description:
The primary objective of this study is to evaluate the safety and immunogenicity of a single intramuscular injection of TAK-850 for 22 days in healthy Japanese adults

Arms:
arm 1: A single dose of 0.5 mL TAK-850 (15 µg of hemagglutinin \[HA\] antigen per strain) is injected into the deltoid muscle.

Interventions: intervention 1: TAK-850
Intervention descriptions: intervention 1: TAK-850 injection

Protocol document: